These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 30315622)

  • 41. Implementation of a national bundle care program to reduce central line-associated bloodstream infections in intensive care units in Taiwan.
    Lai CC; Cia CT; Chiang HT; Kung YC; Shi ZY; Chuang YC; Lee CM; Ko WC; Hsueh PR;
    J Microbiol Immunol Infect; 2018 Oct; 51(5):666-671. PubMed ID: 29108783
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Challenging the 48-Hour Rule-Out for Central Line-Associated Bloodstream Infections in the Pediatric Intestinal Failure Population: A Retrospective Pilot Study.
    Chang MI; Carlson SJ; Nandivada P; O'Loughlin AA; Potemkin AK; Cowan E; Mitchell PD; Gura KM; Puder M
    JPEN J Parenter Enteral Nutr; 2016 May; 40(4):567-73. PubMed ID: 25567785
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Review of Pediatric Central Line-Associated Bloodstream Infections Reported to the National Healthcare Safety Network: United States, 2016-2022.
    Prestel C; Fike L; Patel P; Dudeck M; Edwards J; Sinkowitz-Cochran R; Kuhar D
    J Pediatric Infect Dis Soc; 2023 Sep; 12(9):519-521. PubMed ID: 37688537
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Automated surveillance for central line-associated bloodstream infection in intensive care units.
    Woeltje KF; Butler AM; Goris AJ; Tutlam NT; Doherty JA; Westover MB; Ferris V; Bailey TC
    Infect Control Hosp Epidemiol; 2008 Sep; 29(9):842-6. PubMed ID: 18713052
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk factors for central line-associated bloodstream infection in pediatric oncology patients with a totally implantable venous access port: A cohort study.
    Viana Taveira MR; Lima LS; de Araújo CC; de Mello MJ
    Pediatr Blood Cancer; 2017 Feb; 64(2):336-342. PubMed ID: 27666952
    [TBL] [Abstract][Full Text] [Related]  

  • 46. On the CUSP: Stop BSI: evaluating the relationship between central line-associated bloodstream infection rate and patient safety climate profile.
    Weaver SJ; Weeks K; Pham JC; Pronovost PJ
    Am J Infect Control; 2014 Oct; 42(10 Suppl):S203-8. PubMed ID: 25239711
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The use of 3.15% chlorhexidine gluconate/70% alcohol hub disinfection to prevent central line-associated bloodstream infections in dialysis patients.
    Marty Cooney R; Manickam N; Becherer P; Harmon LS; Gregg L; Farkas Z; Shea LM; Parekh P; Murphy J; Shade W
    Br J Nurs; 2020 Jan; 29(2):S24-S26. PubMed ID: 31972108
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preventing CLABSIs among pediatric hematology/oncology inpatients: national collaborative results.
    Bundy DG; Gaur AH; Billett AL; He B; Colantuoni EA; Miller MR;
    Pediatrics; 2014 Dec; 134(6):e1678-85. PubMed ID: 25404721
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reorganization of nutritional therapy can markedly reduce the rate of catheter-related blood stream infections in pediatric patients receiving parenteral nutrition - a 7-year prospective follow-up study.
    Szlagatys-Sidorkiewicz A; Borkowska A; Jankowska A; Sroka M; Zagierski M; Gosk A; Słomińska-Frączek M; Bogowski G; Plata-Nazar K; Sznurkowska K; Krzykowski G; Kamińska B
    Nutr Hosp; 2014 Dec; 31(3):1116-21. PubMed ID: 25726201
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of a Clinical Prediction Model for Central Line-Associated Bloodstream Infection in Children Presenting to the Emergency Department.
    Figueroa-Phillips LM; Bonafide CP; Coffin SE; Ross ME; Guevara JP
    Pediatr Emerg Care; 2020 Nov; 36(11):e600-e605. PubMed ID: 30985631
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk factors for bacteremia and central line-associated blood stream infections in children with acute myelogenous leukemia: A single-institution report.
    Rogers AE; Eisenman KM; Dolan SA; Belderson KM; Zauche JR; Tong S; Gralla J; Hilden JM; Wang M; Maloney KW; Dominguez SR
    Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27616655
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of the multimodal intervention including an automatic notification of catheter days on reducing central line-related bloodstream infection: a retrospective, observational, quasi-experimental study.
    Bae S; Kim Y; Chang HH; Kim S; Kim HJ; Jeon H; Cho J; Lee J; Chae H; Han G; Kim SW
    BMC Infect Dis; 2022 Jul; 22(1):604. PubMed ID: 35804323
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intravascular Catheter-Related Bloodstream Infections: Contemporary Issues Related to a Persistent Problem.
    Torres CJ; Rupp ME; Cawcutt KA
    Infect Dis Clin North Am; 2024 Dec; 38(4):641-656. PubMed ID: 39261142
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CLABSI reduction using evidence based interventions and nurse empowerment: a quality improvement initiative from a tertiary care NICU in Pakistan.
    Hussain AS; Ahmed AM; Arbab S; Ariff S; Ali R; Demas S; Zeb J; Rizvi A; Saleem A; Farooqi J
    Arch Dis Child; 2021 Apr; 106(4):394-400. PubMed ID: 32253277
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Implementation of a central line maintenance care bundle in hospitalized pediatric oncology patients.
    Rinke ML; Chen AR; Bundy DG; Colantuoni E; Fratino L; Drucis KM; Panton SY; Kokoszka M; Budd AP; Milstone AM; Miller MR
    Pediatrics; 2012 Oct; 130(4):e996-e1004. PubMed ID: 22945408
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Surveillance of catheter-associated bloodstream infections: development and validation of a fully automated algorithm.
    Catho G; Fortchantre L; Teixeira D; Galas-Haddad M; Boroli F; Chraïti MN; Abbas M; Harbarth S; Buetti N;
    Antimicrob Resist Infect Control; 2024 Apr; 13(1):38. PubMed ID: 38600526
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Implementing and validating a home-infusion central-line-associated bloodstream infection surveillance definition.
    Keller SC; Hannum SM; Weems K; Oladapo-Shittu O; Salinas AB; Marsteller JA; Gurses AP; Klein EY; Shpitser I; Crnich CJ; Bhanot N; Rock C; Cosgrove SE;
    Infect Control Hosp Epidemiol; 2023 Nov; 44(11):1748-1759. PubMed ID: 37078467
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of central line bundle on central line-associated bloodstream infections in intensive care units.
    Jeong IS; Park SM; Lee JM; Song JY; Lee SJ
    Am J Infect Control; 2013 Aug; 41(8):710-6. PubMed ID: 23394886
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Active surveillance and safety organizational goals to reduce central line-associated bloodstream infections outside the intensive care unit: 9 years of experience.
    Castagna HM; Kawagoe JY; Gonçalves P; Menezes FG; Toniolo AR; Silva CV; Cardoso MF; Santos CM; Correa L
    Am J Infect Control; 2016 Sep; 44(9):1058-60. PubMed ID: 27156199
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnosing and reporting of central line-associated bloodstream infections.
    Beekmann SE; Diekema DJ; Huskins WC; Herwaldt L; Boyce JM; Sherertz RJ; Polgreen PM;
    Infect Control Hosp Epidemiol; 2012 Sep; 33(9):875-82. PubMed ID: 22869260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.